Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yeon Joo Kim

Showing results (21-30 of 198) with videos related to

Pageof 20
Sort By:
Japanese Journal of Clinical Oncology|June 25, 2020
Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancerWon Kyung Cho, Yeon Joo Kim, Hakyoung Kim, et al.
Clinical Nuclear Medicine|October 10, 2018
Prognostic Value of Volumetric Parameters of Pretreatment 18F-FDG PET/CT in Esophageal Cancer: A Systematic Review and Meta-analysisSangwon Han, Yeon Joo Kim, Sungmin Woo, et al.
Gynecologic Oncology|March 7, 2020
Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapyHakyoung Kim, Won Kyung Cho, Yeon Joo Kim, et al.
Taiwanese Journal of Obstetrics & Gynecology|April 1, 2022
Is the pathologic tumor size associated with survival in early cervical cancer treated with radical hysterectomy and adjuvant radiotherapy?Won Kyung Cho, Won Park, Hakyoung Kim, et al.
BMC Cancer|September 17, 2021
Prevention of radiotherapy induced enteropathy by probiotics (PREP): protocol for a double-blind randomized placebo-controlled trialYeon Joo Kim, Jesang Yu, Sung Pyo Park, et al.
Trials|April 4, 2018
Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trialYeon Joo Kim, Hanjong Ahn, Choung-Soo Kim, et al.
Trials|October 22, 2021
Salvage hypofractionated accelerated versus standard radiotherapy for the treatment of biochemical recurrence after radical prostatectomy (SHARE): the protocol of a prospective, randomized, open-label, superiority, multi-institutional trialGeumju Park, Yeon Joo Kim, Hanjong Ahn, et al.
Cancer Research and Treatment|January 18, 2022
Assessment of Anti-tumor Efficacy of Osimertinib in Non-Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural EffusionYeon Joo Kim, Won Jun Ji, Jae-Cheol Lee, et al.
Korean Journal of Urology|November 17, 2015
A novel one lobe technique of thulium laser enucleation of the prostate: 'All-in-One' techniqueYeon Joo Kim, Yoon Hyung Lee, Joon Beom Kwon, et al.
Journal of Biochemistry and Molecular Biology|December 21, 2004
Hepatitis C virus core protein is efficiently released into the culture medium in insect cellsSoo Ho Choi, So Yeon Kim, Kyu Jin Park, et al.
Pageof 20

Showing results (21-30 of 198) with videos related to

Sort By:
Pageof 20
Japanese Journal of Clinical Oncology|June 25, 2020
Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancerWon Kyung Cho, Yeon Joo Kim, Hakyoung Kim, et al.
Clinical Nuclear Medicine|October 10, 2018
Prognostic Value of Volumetric Parameters of Pretreatment 18F-FDG PET/CT in Esophageal Cancer: A Systematic Review and Meta-analysisSangwon Han, Yeon Joo Kim, Sungmin Woo, et al.
Gynecologic Oncology|March 7, 2020
Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapyHakyoung Kim, Won Kyung Cho, Yeon Joo Kim, et al.
Taiwanese Journal of Obstetrics & Gynecology|April 1, 2022
Is the pathologic tumor size associated with survival in early cervical cancer treated with radical hysterectomy and adjuvant radiotherapy?Won Kyung Cho, Won Park, Hakyoung Kim, et al.
BMC Cancer|September 17, 2021
Prevention of radiotherapy induced enteropathy by probiotics (PREP): protocol for a double-blind randomized placebo-controlled trialYeon Joo Kim, Jesang Yu, Sung Pyo Park, et al.
Trials|April 4, 2018
Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trialYeon Joo Kim, Hanjong Ahn, Choung-Soo Kim, et al.
Trials|October 22, 2021
Salvage hypofractionated accelerated versus standard radiotherapy for the treatment of biochemical recurrence after radical prostatectomy (SHARE): the protocol of a prospective, randomized, open-label, superiority, multi-institutional trialGeumju Park, Yeon Joo Kim, Hanjong Ahn, et al.
Cancer Research and Treatment|January 18, 2022
Assessment of Anti-tumor Efficacy of Osimertinib in Non-Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural EffusionYeon Joo Kim, Won Jun Ji, Jae-Cheol Lee, et al.
Korean Journal of Urology|November 17, 2015
A novel one lobe technique of thulium laser enucleation of the prostate: 'All-in-One' techniqueYeon Joo Kim, Yoon Hyung Lee, Joon Beom Kwon, et al.
Journal of Biochemistry and Molecular Biology|December 21, 2004
Hepatitis C virus core protein is efficiently released into the culture medium in insect cellsSoo Ho Choi, So Yeon Kim, Kyu Jin Park, et al.
Pageof 20